AMH and polycystic ovary syndrome: Recently, a secondary analysis of data from two multicenter randomized clinical trials including a non-IVF PCOS population indicated that 62% of participants who delivered preterm had AMH levels above the 75th percentile (>9.3 ng/ml) (8).